The Gross Margin of NeuroScientific Biopharmaceuticals Ltd (NSB.AX) is 87.52%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-06-30 | 87.52% |
| 2023-06-30 | 99.07% |
| 2022-06-30 | 96.19% |